Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research progress of right unilateral electroconvulsive therapy for major depressive disorder

Download as PDF

DOI: 10.23977/medsc.2023.040117 | Downloads: 15 | Views: 384


Li Qiao 1, Tan Pei 2


1 Department of Rehabilitation, Chongqing Mental Health Center, Chongqing, 400020, China
2 Department of Early Intervention on Mental Illness, Chongqing Mental Health Center, Chongqing, 400020, China

Corresponding Author

Tan Pei


Major depressive disorder (MDD) is the most prevalent form of neuropsychiatric disorder and a leading cause of disability in many developed countries. The efficacy of ECT in the treatment of major depression has been demonstrated by numerous studies over the past decades. However, the use of right unilateral (RUL) and bilateral (BL) ECT has been controversial. Therefore, this study aimed to compare the efficacy of RUL ECT and BL ECT for the treatment of depression. We reviewed studies on major depression and found that high-dose short-pulse right unilateral ECT for depression appears to be as effective as short-pulse biphasic ECT and appears to confer some cognitive advantages.


Major depressive disorder; Electroconvulsive therapy; Right unilateral electroconvulsive therapy; Bilateral unilateral electroconvulsive therapy


Li Qiao, Tan Pei, Research progress of right unilateral electroconvulsive therapy for major depressive disorder. MEDS Clinical Medicine (2023) Vol. 4: 111-115. DOI:


[1] Kessler R. C. & Bromet E. J. (2013). The epidemiology of depression across cultures. Annual review of public health, 34, 119-138.
[2] Prudic J. Olfson M. Marcus S. C. Fuller R. B. & Sackeim H. A. (2004). Effectiveness of electroconvulsive therapy in community settings. Biological psychiatry, 55(3), 301-312.
[3] Pinna M. Manchia M. Oppo R. Scano F. Pillai G. Loche A. P. ... & Minnai G. P. (2018). Clinical and biological predictors of response to electroconvulsive therapy (ECT): a review. Neuroscience letters, 669, 32-42.
[4] Vos, T. Abajobir A. A. Abate K. H. Abbafati C. Abbas K. M. Abd-Allah F. ... & Criqui M. H. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1211-1259.
[5] Fisher L. J. Goldney R. D. Furze P. F. Williams J. L. Mattner J. & McCleave D. J. (2004). Electroconvulsive therapy, depression, and cognitive outcomes: an Australian audit. The Journal of ECT, 20(3), 174-178.
[6] McCall W. V. Prudic J. Olfson M. & Sackeim H. (2006). Health-related quality of life following ECT in a large community sample. Journal of Affective Disorders, 90(2-3), 269-274.
[7] Marano C. M. Phatak P. Vemulapalli U. R. Sasan A. Nalbandyan M. R. Ramanujam S. & Regenold W. T. (2007). Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. Journal of Clinical Psychiatry, 68(4), 512-517.
[8] Bocchio-Chiavetto L. Zanardini R. Bortolomasi M. Abate M. Segala M. Giacopuzzi M. ... & Gennarelli M. (2006). Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. European Neuropsychopharmacology, 16(8), 620-624.
[9] Rahman S. (2015). Targeting brain nicotinic acetylcholine receptors to treat major depression and co-morbid alcohol or nicotine addiction. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 14(5), 647-653.
[10] Deng Z. D. Argyelan M. Miller J. Quinn D. K. Lloyd M. Jones T. R & Abbott C. C. (2022). Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes. Molecular psychiatry, 27(3), 1676-1682.
[11] Espinoza R. T., & Kellner C. H. (2022). Electroconvulsive therapy. New England Journal of Medicine, 386(7), 667-672.
[12] Kolshus E. Jelovac A. & McLoughlin D. M. (2017). Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials. Psychological Medicine, 47(3), 518-530.

Downloads: 3912
Visits: 170375

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.